Clinical Trials
2 trialsNCT06496373 2025-11-17
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT06326736 2024-03-22
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting